Showing results (21-30 of 375) with videos related to
Sort By:
Pageof 38
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 1991
Plasmatic factors of haemostasis remain essentially unchanged except for PAI activity during n-3 fatty acid intake in type I diabetes mellitusM Spannagl, C Drummer, H Fröschl, et al.Archives of Dermatology|June 1, 1993
Treatment of coumarin-induced skin necrosis with a monoclonal antibody purified protein C concentrateW Schramm, M Spannagl, K A Bauer, et al.Contraception|January 12, 1999
Normalized activated protein C ratio itself not associated with increased risk of venous thromboembolismL A Heinemann, A Assmann, M Spannagl, et al.Anesthesiology|December 1, 1990
Influence of high-dose aprotinin treatment on blood loss and coagulation patterns in patients undergoing myocardial revascularizationW Dietrich, M Spannagl, M Jochum, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1993
A new immunoassay for soluble fibrin enables a more sensitive detection of the activation state of blood coagulation in vivoH Lill, M Spannagl, A Trauner, et al.Der Unfallchirurg|February 1, 1992
[Biochemical factors as objective parameters for assessing the prognosis in polytrauma]D Nast-Kolb, C Waydhas, M Jochum, et al.Current Drug Targets|November 1, 2006
Thrombin inhibitors and anti-factor Xa agents in the treatment of arterial occlusionV Klauss, M SpannaglHamostaseologie|December 5, 2013
Direct oral anticoagulants and antiplatelet agents. Clinical relevance and options for laboratory testingD Sibbing, M SpannaglDer Anaesthesist|October 14, 2009
[New oral anticoagulants. Consequences for perioperative coagulation diagnostics and therapy]B Heindl, M SpannaglDer Anaesthesist|November 26, 2013
[Perioperative management of patients with hemophilia]S Lison, M SpannaglPageof 38